Know where sales should spend time
Understand why an account matters now
See who influences the decision
Move from research to outreach faster
The real challenge is not finding more companies and contacts. It is knowing where to focus, why the timing matters, and what will make the outreach relevant.
A large market does not tell your team which accounts are most likely to deserve attention now.
Business events are easy to miss—and even harder to interpret without the right account and sales context.
A verified email is not a strategy. Your team needs the likely need, the right buyer, and a credible reason to engage.
Give marketing, sales, and RevOps a shared view of which accounts matter, who to engage, and why the opportunity deserves attention.
Know whether the company fits your ICP, territory, exclusions, and commercial priorities.
See the decision-makers, influencers, and operational owners connected to the likely need.
Understand the business event, timing, evidence, and potential reason for a conversation.
Give your team a prioritized next action, relevant context, and CRM-ready intelligence.
Move from a broad market to a prioritized view of the accounts, events, buyers, and next actions that can create pipeline.
Which accounts deserve attention?
Why does the timing matter?
Who influences the decision?
What should sales do next?
You bring the growth objective. We turn it into a focused research model and deliver intelligence your team can use immediately.
Align the research around your offer, ICP, territory, buyer roles, exclusions, and the decisions your team needs to make.
Build the relevant account universe and uncover the company, buyer, contact, and commercial context around it.
Review entity matches, sources, dates, buyer relevance, contact details, and evidence before anything is prioritized.
Receive human-reviewed intelligence ready for CRM, ABM, outbound, territory planning, and sales review.
Apply one core intelligence capability to the accounts, signals, entities, and buying structures that matter in your market.
Providers, practices, facilities, affiliations, ownership, expansion, technology, and operational buyer intelligence.
Provider & Facility IntelligenceTechnology adoption, replacement, migration, hiring, integration, AI readiness, and buying-committee signals.
Technology Change IntelligenceFacilities, installed equipment, projects, permits, maintenance cycles, contractors, and operational stakeholders.
Installed-Base IntelligenceRegulatory exposure, security events, governance needs, deadlines, affected companies, and accountable leaders.
Regulatory Opportunity IntelligenceTransactions, investment, leadership, expansion, portfolio changes, succession, and client opportunity signals.
Client & Transaction IntelligenceWhite-label market research, account intelligence, buying signals, decision-maker mapping, and recurring data delivery.
White-Label Intelligence InfrastructureAlso suitable for: logistics, supply chain, public-sector suppliers, construction, energy, telecom, recruitment, real estate, education technology, business services, and specialized B2B markets.
Don’t see your industry? If the market is fragmented, regulated, or difficult to research, we can build a custom intelligence model around it.
Inspect the account fit, buying context, evidence, decision-makers, and recommended next action—not just another contact record.
Multi-location healthcare provider · United States · 850 employees · Estimated $250M revenue
Commercial summary: Rapid expansion may create pressure around scheduling, revenue cycle, staffing, patient acquisition, and operational consistency—making this a timely account for relevant healthcare technology and service providers.
| Buyer | Why They Matter |
|---|---|
| Chief Operating Officer | Owns operational scale and performance across locations |
| Director of Operations | Leads workflow, staffing, and implementation priorities |
| Revenue Cycle Director | Responsible for billing efficiency and revenue performance |
| Chief Financial Officer | Approves budget and evaluates financial impact |
| Name | Role | Business Email | Verification |
|---|---|---|---|
| Alex Morgan | Chief Operating Officer | a••••@examplehealth.com | Human-reviewed |
| Jordan Lee | Director of Operations | j••••@examplehealth.com | Verified |
| Taylor Smith | Revenue Cycle Director | t••••@examplehealth.com | Verified |
Delivered CRM-ready: qualified account, commercial summary, evidence with source references, buying committee, verified contacts, technology context, priority score, and recommended next action.
Choose the lowest-risk path for your use case—test a market, build a complete intelligence view, or keep opportunities flowing over time.
Test a niche, market, or campaign before committing to a larger build.
Give your team a structured, prioritized view of a market, territory, or account universe.
Keep your revenue team informed as new accounts, signals, role changes, and opportunities emerge.
Your team gets the researched commercial context around the account—not another alert, export, or raw event to interpret.
Your offer, ICP, territory, exclusions, relevant events, evidence standards, and sales workflow shape the engagement.
Important signals are connected to the right company, date, source, likely need, buyer responsibility, and confidence level.
Human researchers investigate fragmented sources and difficult buyer structures that standard databases may not fully explain.
Your team receives a finished opportunity structured for CRM, ABM, outbound, territory planning, partner development, or sales review.
Bring difficult markets, complex buyer structures, and custom research requirements to a team built to handle the details.
Detailed anonymized samples and relevant project examples are available during qualification.
Clear answers before you invest time in a pilot or larger engagement.
No. Infinizy is a managed research and intelligence service built around your market, ICP, offer, buyer roles, and sales workflow.
Depending on the scope, you may receive qualified accounts, verified business signals, supporting evidence, buying-committee contacts, opportunity priorities, outreach context, and CRM-ready records.
Yes. We can validate, enrich, segment, deduplicate, resolve company structures, map buying committees, and prioritize existing accounts.
Yes. Clearly defined, fragmented, regulated, and research-intensive markets are often where a custom approach creates the greatest value.
Important information is human-reviewed against relevant sources and delivered with agreed validation fields, dates, evidence, and confidence indicators where applicable.
Yes. Begin with a focused sample or pilot so your team can evaluate the research logic, evidence quality, structure, and sales relevance before scaling.
Tell us what you sell, who you want to reach, and where your team needs greater clarity. We will prepare a focused example built around your market and sales use case.